Bob: "Adding 3-4 million shares to a 30 M o/s count is peanuts"
It is currently a little more than 30 million. The last count is over 42 M o/s and fully diluted, warrants and options of over 56 M. The dilutive factor is becoming significant and especially starting into therapeutics which will necessitate even a greater rate. I think they should have stuck to the plan of waiting for money from Abbott.